Clinical Trials in Chur, Kanton Graubünden
16 recruiting
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Ovarian CancerOvarian Neoplasms
Merck Sharp & Dohme LLC900 enrolled28 locationsNCT07318558
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled288 locationsNCT06393374
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Merck Sharp & Dohme LLC780 enrolled260 locationsNCT06312137
Recruiting
Phase 1Phase 2
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC160 enrolled50 locationsNCT06469944
Recruiting
Phase 1Phase 2
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC210 enrolled44 locationsNCT06445972
Recruiting
Phase 1Phase 2
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC298 enrolled42 locationsNCT06780111
Recruiting
Phase 1Phase 2
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC230 enrolled57 locationsNCT05319730
Recruiting
Registry for Automated Mechanical VEntilation in Adults
Respiratory Insufficiency Requiring Mechanical Ventilation
Hamilton Medical AG1,000 enrolled4 locationsNCT06655805
Recruiting
Phase 2
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Breast Cancer
Swiss Cancer Institute50 enrolled8 locationsNCT06452394
Recruiting
Phase 3
High Dose Steroids in Children With Stroke
Paediatric Stroke
Insel Gruppe AG, University Hospital Bern70 enrolled35 locationsNCT04873583
Recruiting
Not Applicable
STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room
Communication ResearchCommunication, Multidisciplinary
Insel Gruppe AG, University Hospital Bern400 enrolled13 locationsNCT05356962
Recruiting
Phase 2
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease
Cantonal Hospital Graubuenden40 enrolled2 locationsNCT06435858
Recruiting
Not Applicable
A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
Community Acquired Pneumonia in ChildrenMycoplasma PneumoniaeMycoplasma Pneumoniae Pneumonia
Christoph Berger376 enrolled13 locationsNCT06325293
Recruiting
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Multiple SclerosisOptic NeuritisTransverse Myelitis+15 more
University of Bern500 enrolled13 locationsNCT05017142
Recruiting
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Sarcoma
Kantonsspital Winterthur KSW600 enrolled8 locationsNCT04300257
Recruiting
The SwissPrEPared Study
HIV Preexposure Prophylaxis
University of Zurich3,000 enrolled41 locationsNCT03893188